FDA pulls Covid antibody treatment because it's not effective against dominant omicron variantsCNBC • 12/01/22
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic DiseasesPRNewsWire • 12/01/22
Lilly Shares Positive Donanemab Data in First Active Comparator Study in Early Symptomatic Alzheimer's DiseasePRNewsWire • 11/30/22
Eli Lilly and Company (LLY) Management Presents at 5th Annual Evercore ISI HealthCONx Conference 2022 Conference Call TranscriptSeeking Alpha • 11/30/22
Is DICE Therapeutics (DICE) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 11/30/22
Lilly Confirms Date and Conference Call for 2023 Financial Guidance AnnouncementPRNewsWire • 11/29/22
4 Pharmaceutical Companies Among 19 To Announce Annual Dividend Increases In DecemberSeeking Alpha • 11/28/22
Wall Street Analysts Think DICE Therapeutics, Inc. (DICE) Could Surge 93%: Read This Before Placing a BetZacks Investment Research • 11/24/22
Lilly Announces Details of Presentations at 2022 San Antonio Breast Cancer SymposiumPRNewsWire • 11/21/22
‘More work to do': Eli Lilly admits insulin pricing could be lower amid Twitter chaosThe Guardian • 11/19/22
These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher.The Motley Fool • 11/18/22